HN1997000154A - Sales dimesilato de los ligandos del neuropeptido - Google Patents

Sales dimesilato de los ligandos del neuropeptido

Info

Publication number
HN1997000154A
HN1997000154A HN1997000154A HN1997000154A HN1997000154A HN 1997000154 A HN1997000154 A HN 1997000154A HN 1997000154 A HN1997000154 A HN 1997000154A HN 1997000154 A HN1997000154 A HN 1997000154A HN 1997000154 A HN1997000154 A HN 1997000154A
Authority
HN
Honduras
Prior art keywords
dimesylate
salts
neuropeptide ligands
neuropeptide
ligands
Prior art date
Application number
HN1997000154A
Other languages
English (en)
Spanish (es)
Inventor
Pfizer Products Inc
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN1997000154A publication Critical patent/HN1997000154A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HN1997000154A 1996-11-26 1997-11-26 Sales dimesilato de los ligandos del neuropeptido HN1997000154A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
HN1997000154A true HN1997000154A (es) 1999-02-09

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1997000154A HN1997000154A (es) 1996-11-26 1997-11-26 Sales dimesilato de los ligandos del neuropeptido

Country Status (23)

Country Link
US (1) US5914329A (enExample)
EP (1) EP0944611B1 (enExample)
JP (1) JP3120861B2 (enExample)
AP (1) AP9701148A0 (enExample)
AR (1) AR010304A1 (enExample)
AT (1) ATE257472T1 (enExample)
AU (1) AU4792497A (enExample)
BR (1) BR9713538A (enExample)
CA (1) CA2272927C (enExample)
DE (1) DE69727155T2 (enExample)
DK (1) DK0944611T3 (enExample)
ES (1) ES2213207T3 (enExample)
GT (1) GT199700123A (enExample)
HN (1) HN1997000154A (enExample)
HR (1) HRP970640A2 (enExample)
ID (1) ID18964A (enExample)
MA (1) MA26450A1 (enExample)
PA (1) PA8441701A1 (enExample)
PE (1) PE17099A1 (enExample)
PT (1) PT944611E (enExample)
TN (1) TNSN97191A1 (enExample)
WO (1) WO1998023603A1 (enExample)
ZA (1) ZA9710587B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001232900A1 (en) * 2000-01-20 2001-07-31 Michael Amling Methods and compositions for control of bone formation via modulation of neuropeptide y activity
JP2005516001A (ja) 2001-12-05 2005-06-02 ベイラー カレッジ オブ メディスン 交感神経活動状態の調節による骨形成の制御のための方法及び組成物
NZ533848A (en) 2002-01-09 2006-11-30 Arexis Ab Detection of mutations in the flavin-containing monooxygenase (FMO3) gene
EP1701722B1 (en) * 2004-11-23 2009-10-14 Dong Wha Pharmaceutical Co., Ltd. N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy¨]pentoxy}benzamidine 2 methansulfonic acid salt
EP1877076A4 (en) * 2005-04-15 2012-02-01 Regenertech Pty Ltd USE OF NEUROPEPTIDES Y (NPY) AND AGONIST OF ANTAGONISTS THEREOF FOR REGENERATING TISSUES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK57097A3 (en) * 1994-11-07 1998-10-07 Pfizer Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands

Also Published As

Publication number Publication date
AP9701148A0 (en) 1998-01-31
ES2213207T3 (es) 2004-08-16
ATE257472T1 (de) 2004-01-15
AU4792497A (en) 1998-06-22
JP3120861B2 (ja) 2000-12-25
GT199700123A (es) 1999-05-19
JP2000505110A (ja) 2000-04-25
ID18964A (id) 1998-05-28
PA8441701A1 (es) 2000-05-24
CA2272927A1 (en) 1998-06-04
MA26450A1 (fr) 2004-12-20
DE69727155D1 (de) 2004-02-12
CA2272927C (en) 2003-02-04
PE17099A1 (es) 1999-02-19
DK0944611T3 (da) 2004-04-13
TNSN97191A1 (fr) 2005-03-15
US5914329A (en) 1999-06-22
DE69727155T2 (de) 2004-07-08
HRP970640A2 (en) 1998-10-31
BR9713538A (enExample) 2000-03-21
ZA9710587B (en) 1999-05-25
AR010304A1 (es) 2000-06-07
PT944611E (pt) 2004-04-30
EP0944611B1 (en) 2004-01-07
WO1998023603A1 (en) 1998-06-04
EP0944611A1 (en) 1999-09-29

Similar Documents

Publication Publication Date Title
HN1997000126A (es) Derivados de indazol
HN1997000090A (es) Compuestos de piridilpirrol
HN1998000175A (es) Imidazotriazininas
HN1998000132A (es) Combinaciones terapeuticas
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
HN1997000023A (es) Derivados de lactama
HN1997000099A (es) Inhibidores de metaloproteasas matriciales basados en
HN1997000149A (es) Derivados de 6 fenilpiridil 2 amina
HN1998000124A (es) Terapia de combinacion
HN1998000011A (es) Derivados de acidos arilsulfonilaminohidroxamicos
HN1997000166A (es) 1-arilpirazoles plaguicidas
HN1994000083A (es) Aparato de cierre
HN1997000079A (es) Analogos de indazol sustituido.
HN1997000083A (es) Derivados triciclicos sustituidos con fenilamino
HN1997000146A (es) Derivados de pirimidina biciclica condensada
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998000118A (es) 2 - aminopiridinas que contienen sustituyentes de anillos condensados.
HN1998000193A (es) Compuestos de triazina
HN1998000199A (es) Agentes terapeuticos
HN1997000154A (es) Sales dimesilato de los ligandos del neuropeptido
HN1997000138A (es) Caramelo juguete
ES2169101T3 (es) Compuesto de metaloceno.
HN1998000102A (es) Composiciones solubilizadas de sertralina
HN1998000087A (es) Compuestos de amonio cuaternario